Founded in 1999, Asymchem is a global integrated CDMO providing drug R&D and manufacturing for leading pharmaceutical and biotech companies. The company's mission is to drive smarter, greener and more cost-effective manufacturing to support clinical research and commercialisation.
Asymchem currently operates eight manufacturing facilities offering solutions ranging from early clinical stage to commercial stage, including R&D, cGMP production of advanced intermediates, APIs, formulations and clinical research services.
The company's scientists excel in the creation and manufacture of enzymes for use in bio-catalysis, the development of practical continuous flow technologies for commercialisation, and innovative research and process development from preclinical research to commercialisation for both non-GMP or GMP products. The work has frequently won them “most valuable partner” and “strategic partner” recognition from major pharma and leading biotech companies. For more information, please visit www.asymchem.com.
